Investing - Small-Cap Market Intelligence

Investing - Small-Cap Market Intelligence

Micro and small cap, investor relations, and financial news.

Subscribe Watch Trailer Share
Investing - Small-Cap Market Intelligence
  • CIIX High Growth Investment Opportunity Targeting Chinese Speaking Communities

    ChineseInvestors.com (OTCQB: CIIX) has built a large base of Chinese-speaking consumers over its 20-year history. Since its founding in 1999, the company focused on providing financial news and information through its proprietary platform ChineseInvestors.com, which continues to generate subscrip...

  • Can-Fite BioPharma Ltd. (NYSE American: CANF)

    Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical-stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases includi...

  • Ethema Health: New Paradigm in Mental Health Treatment

    Ethema Health Corporation (OTCQB: GRST) operates in the behavioral healthcare space, specifically in the treatment of substance-use disorders. The company has developed a unique treatment model that has shown to be highly effective at treating opioid addiction. Launched in 2011, Ethema plans to o...

  • Cyclo Therapeutics (CTDH)

    Cyclo Therapeutics (CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare...

  • Developing Innovative Treatments for Alzheimer's

    Cyclo Therapeutics (CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare...

  • Interview with iSIGN CEO Philip Sassower

    iSIGN (OTC: ISGN) is a leading provider of digital transaction management (DTM) software enabling fully digital (paperless) business processes. iSIGN’s solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and variou...

  • CTD Holdings (OTCQB: CTDH)

    CTD Holdings (OTCQB: CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rar...

  • SG Blocks (NASDAQ: SGBX)

    Watch our exclusive interview with SG Blocks (NASDAQ: SGBX), a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction. SGBX offers a product that exceeds many standard building code requirements, and also supports de...

  • Elixinol (OTCQX: ELLXF)

    Watch our exclusive interview with Elixinol (OTCQX: ELLXF) co-founder Paul Benhaim. Elixinol is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands wit...

  • cbdMD (NYSE American: YCBD)

    Exclusive Interview with cbdMD (NYSE American: YCBD) CEO Marty Sumichrast discussing the company's rapid growth in a multi-billion-dollar market. The relative newcomer to its industry surpassed a $20M annual revenue run rate in its second quarter of fiscal year 2019 (ended March) and is well-posi...

  • Wuhan General (OTC: WUHN)

    Watch our exclusive interview with the CEOs of MJ MedTech, a subsidiary of Wuhan General (OTC: WUHN), and Biodelta, as they discuss the company's near-term rollout in South Africa and plans to expand into neighboring countries. An early entrant in a multi-billion-dollar market opportunity, WUHN i...

  • Intellicheck (NYSE American: IDN)

    Watch RedChip's exclusive interview with Intellicheck's CEO Bryan Lewis. Intellicheck (NYSE American: IDN) is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identity authentication and age verification. We make it possible for our clients to in...

  • Solar Business Generating Rapid Sales Growth for SinglePoint

    Exclusive interview with Greg Lambrecht, CEO of SinglePoint (OTCQB: SING). SinglePoint is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company acquired Direct Solar in May and generat...

  • Dr. Faz Chowdhurry, CEO of Nemaura Medical

    RedChip's exclusive interview with Dr. Faz Chowdhurry, CEO of Nemaura Medical (NASDAQ: NMRD). Nemaura is a medical technology company developing SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and pre-diabetics better ma...

  • Wize Pharma Developing Innovative Treatments for Dry Eyes

    Wize Pharma_ Developing Innovative Treatments for Dry Eyes

  • ChineseInvestors.com (OTCQB: CIIX)

    ChineseInvestors.com (OTCQB: CIIX) - Targeting Chinese Consumers and Investors in North America

  • Green Organic

    Green Organic Dutchman Rapidly Growing Operations Globally

  • Emerald Health

    Emerald Health Growing Operations in Multi-Billion-Dollar Markets Globally

  • Genetic Technologies

    Genetic Technologies New Risk Tests for Breast and Colorectal Cancers

  • Piedmont Lithium Only Conventional US Lithium Development Project

    Piedmont Lithium: Only Conventional US Lithium Development Project

  • Cuentas Emerging Leader in Fintech Solving Large Unmet Need

    Cuentas Emerging Leader in Fintech Solving Large Unmet Need

  • Electra Meccanica Sales Growing for Innovative 1- and 2-Seat Electric Vehicles

    Electra Meccanica Sales Growing for Innovative 1- and 2-Seat Electric Vehicles

  • Polar Power Innovative Power Solutions for Critical Applications

    Polar Power Innovative Power Solutions for Critical Applications

  • Tenax Therapeutics Near-Term Phase 2 Results Expected to Drive Stock

    Tenax Therapeutics Near-Term Phase 2 Results Expected to Drive Stock